Orthotopic models of esophageal carcinoma and their use in drug discovery.

Standard

Orthotopic models of esophageal carcinoma and their use in drug discovery. / Gros, Stephanie; Stephanie, J.

In: Curr Protoc Pharmacol, Vol. Chapter 14, 2011, p. 20.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{8e14e1ea548f4a52b85b9bea5e443bb3,
title = "Orthotopic models of esophageal carcinoma and their use in drug discovery.",
abstract = "The protocol detailed in this unit is for the establishment of an orthotopic model of human esophageal adenocarcinoma in NMRI/nu mice. The resultant tumor has high metastatic potential, spreading readily to liver, lungs, and lymph nodes. This model is useful for studying primary esophageal carcinoma, tumor biology, pathogenesis, tumor progression, metastatic homing, and the efficacy of therapeutic approaches for treating this condition. The practical use of this preclinical model for drug discovery is illustrated with data from a study on the chemotherapeutic effects of HER2-targeted therapy.",
keywords = "Animals, Humans, Mice, Cell Line, Tumor, Mice, Nude, Antineoplastic Agents/*therapeutic use, Adenocarcinoma/*drug therapy/pathology, Drug Discovery/*methods, Esophageal Neoplasms/*drug therapy/pathology, Xenograft Model Antitumor Assays/*methods, Animals, Humans, Mice, Cell Line, Tumor, Mice, Nude, Antineoplastic Agents/*therapeutic use, Adenocarcinoma/*drug therapy/pathology, Drug Discovery/*methods, Esophageal Neoplasms/*drug therapy/pathology, Xenograft Model Antitumor Assays/*methods",
author = "Stephanie Gros and J Stephanie",
year = "2011",
language = "English",
volume = "Chapter 14",
pages = "20",
journal = "Curr Protoc Pharmacol",
issn = "1934-8290",
publisher = "John Wiley and Sons Inc.",

}

RIS

TY - JOUR

T1 - Orthotopic models of esophageal carcinoma and their use in drug discovery.

AU - Gros, Stephanie

AU - Stephanie, J

PY - 2011

Y1 - 2011

N2 - The protocol detailed in this unit is for the establishment of an orthotopic model of human esophageal adenocarcinoma in NMRI/nu mice. The resultant tumor has high metastatic potential, spreading readily to liver, lungs, and lymph nodes. This model is useful for studying primary esophageal carcinoma, tumor biology, pathogenesis, tumor progression, metastatic homing, and the efficacy of therapeutic approaches for treating this condition. The practical use of this preclinical model for drug discovery is illustrated with data from a study on the chemotherapeutic effects of HER2-targeted therapy.

AB - The protocol detailed in this unit is for the establishment of an orthotopic model of human esophageal adenocarcinoma in NMRI/nu mice. The resultant tumor has high metastatic potential, spreading readily to liver, lungs, and lymph nodes. This model is useful for studying primary esophageal carcinoma, tumor biology, pathogenesis, tumor progression, metastatic homing, and the efficacy of therapeutic approaches for treating this condition. The practical use of this preclinical model for drug discovery is illustrated with data from a study on the chemotherapeutic effects of HER2-targeted therapy.

KW - Animals

KW - Humans

KW - Mice

KW - Cell Line, Tumor

KW - Mice, Nude

KW - Antineoplastic Agents/therapeutic use

KW - Adenocarcinoma/drug therapy/pathology

KW - Drug Discovery/methods

KW - Esophageal Neoplasms/drug therapy/pathology

KW - Xenograft Model Antitumor Assays/methods

KW - Animals

KW - Humans

KW - Mice

KW - Cell Line, Tumor

KW - Mice, Nude

KW - Antineoplastic Agents/therapeutic use

KW - Adenocarcinoma/drug therapy/pathology

KW - Drug Discovery/methods

KW - Esophageal Neoplasms/drug therapy/pathology

KW - Xenograft Model Antitumor Assays/methods

M3 - SCORING: Journal article

VL - Chapter 14

SP - 20

JO - Curr Protoc Pharmacol

JF - Curr Protoc Pharmacol

SN - 1934-8290

ER -